公开(公告)号：US09527879B2

公开(公告)日：2016-12-27

申请号：US14717016

申请日：2015-05-20

Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Hyoung Ja Kim ,  Chang Bae Jin ,  Min Jeoung Son ,  Yong Sup Lee ,  Chang Soo Yook ,  Jae Yeol Lee

IPC: A61K36/00 ,  C07H15/207 ,  A61K36/28 ,  C07H15/10 ,  C07H15/18 ,  A61K31/704

CPC classification number: C07H15/207 ,  A23L33/105 ,  A61K31/704 ,  A61K36/28 ,  A61K2236/00 ,  C07H15/10 ,  C07H15/18

Abstract: The present invention relates to an Aster glehni extract, a fraction thereof and the active compounds isolated therefrom, which are effective for the treatment, prevention and improvement of hyperuricemia or gout. The Aster glehni extract, the fraction thereof and 6′-O-caffeoylampelopsisionoside, 6′-O-caffeoylroseoside, 6′-O-caffeoylsonchuinoside C, 6′-O-caffeoyldihydrosyringin and glehnoside as the active compounds isolated from the fraction according to the present invention have substantial effect of inhibiting production of uric acid and decreasing its concentration. Accordingly, the Aster glehni extract, the fraction thereof and the active compounds isolated therefrom the fraction according to the present invention can be effectively used as an active ingredient of a drug, health food, etc. for the treatment, prevention and improvement of such as hyperuricemia or gout, which are diseases induced by increased level of uric acid.

Abstract translation: 本发明涉及一种有效治疗，预防和改善高尿酸血症或痛风的阿斯特氏提取物及其分离物及其分离的活性化合物。 Aster glehni提取物，其分数和6'-O-咖啡酰罂粟苷苷，6'-O-咖啡酰基糖苷，6'-O-咖啡酰基胆碱酯C，6'-O-咖啡酰二氢肉豆蔻苷和格列本苷作为从根据 本发明具有抑制尿酸生成和降低其浓度的显着效果。 因此，可以有效地使用根据本发明的级分的分解的Aster glehni提取物及其分离的活性化合物作为药物，保健食品等的活性成分，用于治疗，预防和改善诸如 高尿酸血症或痛风是由尿酸水平升高引起的疾病。